Skip to main content

Table 2 Outcomes in cases and controls

From: Chloral hydrate enteral infusion for sedation in ventilated children: the CHOSEN pilot study

Outcome

CHOSEN (n = 21)

Controls (n = 21)

p value

Days on study

 

4.5 (2.2)

-

-

 

4.4 (IQR 2.3, 6.7)

Primary outcomes

 Pre-defined feasibility

21/21 (100%)

-

-

 Any pre-specified adverse effecta

0

0

-

 SAEb

1 (5%)

0

0.99

 Mortality in PICU

0

1 (5%)

0.99

 Post-hoc feasiblity

20/21 (95%)

20/21 (95%)

0.99

Main secondary outcomes

 Days to titration of adequate sedation

1.4 (1.3)

0.9 (1.3)

0.22

1 (IQR 0.5, 2.5)

0.5 (IQR 0, 1.3)

 Hours to awakening

N = 19

N = 18

0.80

8.1 (8.4)

8.8 (8.5)

5 (IQR 2, 9)

8 (IQR 1, 13)

 Fluid balance, 48 h (ml/kg)

−2 (45)

26 (46)

0.051

−7 (IQR −30, 25)

19 (IQR −4, 59)

 Number of prn sedation doses from 12 h pre to 12 h post baseline

4.7 (3.3) to 2.6 (2.8)

2.9 (3.9) to 3.4 (5.0)

0.009/0.74

Other secondary outcomes

 Ventilator hours

125 (84)

258 (363)

0.12

106 (IQR 54, 162)

129 (IQR 63, 191)

 PICU days

9.8 (7.6)

16.8 (21.7)

0.17

8.5 (IQR 5, 13)

8 (IQR 5.5, 12)

 Extubation information

  Propofol used as bridge to extubation

13 (62%)

6 (29%)

0.06

  Failed extubation due to sedation

0/21

0/19

-

 Post-extubation withdrawal syndrome

  Signs of withdrawal

9/20 (45%)

8/19 (42%)

0.99

  Enteral narcotic started within 48 h

3 (15%)

4 (22%)

0.99

  Enteral BDZ started within 48 h

4 (19%)

2 (11%)

0.66

  Enteral clonidine started within 48 h

3 (15%)

2 (11%)

0.99

  Withdrawal score 48 h after extubation

N = 12/21 (57%)

N = 14/21 (67%)

0.53

4.3 (3.3)

2.3 (2.5)

0.10

Fluid balance, 24 h (ml/kg)

5 (32)

24 (31)

0.06

3 (IQR −17, 32)

21 (IQR −3, 49)

  1. Data given as n (%), mean (SD), or median (IQR). Comparisons by Fisher’s exact test and t test or paired t test, as appropriate. PICU pediatric intensive care unit, BDZ benzodiazepine, SAE serious adverse event, prn as required
  2. aPre-specified adverse effects were defined as any of: feeding tube blockage, GI bleeding, new/worse seizure, feed intolerance, or new/worse ventricular dysrhythmia
  3. bChloral hydrate infusion was feasible on day 1 to 7, except for one patient on day 3 due to the SAE (duodenal perforation; see text)